Crohn's Disease and Colitis Trial, Recruiting NCT07444060 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT07444060
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old and have been diagnosed with moderate-to-severe Crohn's disease.
  • You are currently being treated with one of two specific medications: Guselkumab or Ustekinumab.
  • In the past 8 weeks, you have had symptoms suggesting a partial or full blockage in your intestine, including stomach pain after eating that is linked to a narrowing in your bowel (confirm with trial site for exact symptom details).
  • Scans or camera tests (such as a CT scan or endoscopy) have confirmed that there is a real narrowing in your intestine caused by your Crohn's disease, meeting specific measurable criteria on imaging or being too narrow for a camera to pass through.

Who may not be able to join:

  • You need emergency surgery or an urgent procedure, or your doctor believes you will need to change your medication or have planned surgery within the next 2 months.
  • Your bowel narrowing or blockage is caused by a previous surgery, rather than by Crohn's disease itself.
  • You have had a procedure to treat a bowel narrowing in the past 6 months (such as balloon stretching, cutting, or surgical widening of the bowel).
  • You have been unable to eat or drink by mouth for more than 2 months, even with tube feeding support.
  • You have used Guselkumab, Ustekinumab, or similar medications (IL-23 blockers) in the past 12 months, or you have a known allergy or medical reason preventing you from taking these medications.
  • You are unable to have a CT scan, for example due to an allergy to the contrast dye used in the scan.
  • You have certain health conditions that make it unsafe to use biological medicines, such as active tuberculosis, or a history of heart attack, heart failure, or certain nerve conditions in the past 5 years.
  • You currently have or have previously had certain cancers, including solid tumours, lymphoma, or melanoma, or you are currently receiving chemotherapy or radiotherapy.
  • You have certain intestinal conditions such as short bowel syndrome, a stoma (colostomy), or growths in the colon or rectum.
  • You have serious active health problems such as major intestinal bleeding, severe liver or kidney problems, active infection, shock, uncontrollable vomiting, or severe difficulty absorbing nutrients.
  • You are pregnant or breastfeeding.
  • Your overall health condition is very unstable, rapidly worsening, or considered end-stage.
  • You have a psychiatric disorder, or there are concerns about your ability to fully understand and participate in the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86+13757118653

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Continuation of ustekinumab

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov